141 related articles for article (PubMed ID: 32158234)
1. Serum miR-191 and miR-425 as Diagnostic and Prognostic Markers of Advanced Gastric Cancer Can Predict the Sensitivity of FOLFOX Chemotherapy Regimen.
Bie LY; Li N; Deng WY; Lu XY; Guo P; Luo SX
Onco Targets Ther; 2020; 13():1705-1715. PubMed ID: 32158234
[TBL] [Abstract][Full Text] [Related]
2. MiR-92b as a marker for TPF induced chemotherapy response prediction and prognosis evaluation in with advanced oral squamous cell carcinoma patients.
Wen J; Xu H; Liu R; Chen Q; Dai Y; Xu Y
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):24-31. PubMed ID: 32538743
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of miR-135 and miR-20a combined with multi-detector computed tomography in the diagnosis of gastric cancer.
Han W; Bu X; Liu Y; Liu F; Ren Y; Cui Y; Kong S
World J Surg Oncol; 2021 Sep; 19(1):283. PubMed ID: 34537058
[TBL] [Abstract][Full Text] [Related]
4. Serum miR-19a predicts resistance to FOLFOX chemotherapy in advanced colorectal cancer cases.
Chen Q; Xia HW; Ge XJ; Zhang YC; Tang QL; Bi F
Asian Pac J Cancer Prev; 2013; 14(12):7421-6. PubMed ID: 24460313
[TBL] [Abstract][Full Text] [Related]
5. Expression and clinical significance of miR-338 and miR-20a in serum of patients with gastric carcinoma.
Li M; Feng J; Gao C; Sun W; Chen Y
Am J Transl Res; 2021; 13(6):6620-6628. PubMed ID: 34306405
[TBL] [Abstract][Full Text] [Related]
6. Expression of miR-4739 in Gastric cancer and its Relationship with Clinical Pathological Features of Patients.
Wei J; Li J; Geng D; Peng Y; Yang B; Wu H; Zhou Y
Front Surg; 2022; 9():897583. PubMed ID: 35592126
[TBL] [Abstract][Full Text] [Related]
7. Down regulation of miR-30a-5p and miR-182-5p in gastric cancer: Clinical impact and survival analysis.
Soliman SE; Elabd NS; El-Kousy SM; Awad MF
Biochem Biophys Rep; 2021 Sep; 27():101079. PubMed ID: 34355069
[TBL] [Abstract][Full Text] [Related]
8. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
Wang WT; Guo CQ; Cui GH; Zhao S
World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of peripheral blood microRNA detection in evaluation of SOX regimen as neoadjuvant chemotherapy for gastric cancer.
Tan B; Li Y; Di Y; Fan L; Zhao Q; Liu Q; Wang D; Jia N
J Clin Lab Anal; 2018 May; 32(4):e22363. PubMed ID: 29168576
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
Kong Y; Ning L; Qiu F; Yu Q; Cao B
Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
[TBL] [Abstract][Full Text] [Related]
11. [Clinical application value of combined detection of serum miR-378 and miR-21 in gastric cancer].
Huang SK; Wang J; Li Y; Lin H; Li DD; Cui CJ; Wang GJ; Li XX; Yang L; Zhao M; Huang CZ
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):441-445. PubMed ID: 29936770
[No Abstract] [Full Text] [Related]
12. Prognostic potential of miR-21-3p in gastric cancer.
Sun X; Zhang K; Li D
J BUON; 2020; 25(6):2678-2682. PubMed ID: 33455113
[TBL] [Abstract][Full Text] [Related]
13. Serum CXCL13 and PECAM-1 can be used as diagnostic and prognostic markers in elderly patients with gastric cancer.
Li Y; Guo XB; Wei YH; Kang XL
Clin Transl Oncol; 2021 Jan; 23(1):130-138. PubMed ID: 32500259
[TBL] [Abstract][Full Text] [Related]
14. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
[TBL] [Abstract][Full Text] [Related]
15. Preoperative Body Mass Index, Blood Albumin and Triglycerides Predict Survival for Patients with Gastric Cancer.
Liu BZ; Tao L; Chen YZ; Li XZ; Dong YL; Ma YJ; Li SG; Li F; Zhang WJ
PLoS One; 2016; 11(6):e0157401. PubMed ID: 27309531
[TBL] [Abstract][Full Text] [Related]
16. Three dysregulated microRNAs in serum as novel biomarkers for gastric cancer screening.
Wang H; Wang L; Wu Z; Sun R; Jin H; Ma J; Liu L; Ling R; Yi J; Wang L; Bian J; Chen J; Li N; Yuan S; Yun J
Med Oncol; 2014 Dec; 31(12):298. PubMed ID: 25367852
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of serum miR-17 and miR-106b levels in gastric cancer and benign gastric diseases.
Zeng Q; Jin C; Chen W; Xia F; Wang Q; Fan F; Du J; Guo Y; Lin C; Yang K; Li J; Peng X; Li X; Cao K
Chin J Cancer Res; 2014 Dec; 26(6):711-6. PubMed ID: 25561770
[TBL] [Abstract][Full Text] [Related]
18. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D
Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
Sun Z; Zhang N
World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
[TBL] [Abstract][Full Text] [Related]
20. Serum miR-885-5p can be used as a marker for efficacy prediction and prognosis of advanced liver cancer.
Wang K
Cell Mol Biol (Noisy-le-grand); 2020 Sep; 66(6):135-141. PubMed ID: 33040799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
